Old Web
English
Sign In
Acemap
>
authorDetail
>
W. Harwin
W. Harwin
AstraZeneca
Medicine
Breast cancer
Tamoxifen
Gynecology
Anastrozole
4
Papers
1258
Citations
0.02
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Upper Limb Mediated Stroke Therapy – GENTLE/s Approach
2005
R Loureiro
Farshid Amirabdollahian
M Topping
B. Driessen
W. Harwin
Show All
Source
Cite
Save
Citations (0)
Anastrozole I s S uperior t o T amoxifen a s F irst-Line Therapy f or A dvanced B reast C ancer i n P ostmenopausal Women: R esults o f a N orth A merican M ulticenter Randomized T rial
2000
J.-M. Nabholtz
A. Buzdar
Michael Pollak
W. Harwin
G Burton
Aroop Mangalik
Mark Steinberg
Alan Webster
Show All
Source
Cite
Save
Citations (0)
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.
2000
Journal of Clinical Oncology
J. M. Nabholtz
Aman U. Buzdar
Michael Pollak
W. Harwin
Gary V. Burton
Aroop Mangalik
Mark Steinberg
Alan Webster
von Euler M
Show All
Source
Cite
Save
Citations (343)
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
2000
Journal of Clinical Oncology
J. M. Nabholtz
Aman U. Buzdar
Michael Pollak
W. Harwin
G. Burton
Aroop Mangalik
Mark Steinberg
Alan Webster
M. von Euler
Show All
Source
Cite
Save
Citations (915)
1